Turning Pennies into dollars: (NASD: OCCX), (OTCBB: SGZH), (OTC: AQUI), (OTCBB: UDTT).
Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559
For more info: http://occx.realpennies.com
OccuLogix, Inc., an ophthalmic therapeutic company, provides treatments for eye diseases. Its treatments primarily include age-related macular degeneration and glaucoma. The company develops RHEO System, which consists of the OctoNova Pump and a disposable treatment set, is designed to improve microcirculation in the eye by filtering high molecular weight proteins and other macromolecules from the patient's plasma. OccuLogix operates in the United States, Canada, Europe, and Israel. The company was founded in 1996 and is headquartered in Mississauga, Canada.
April 10,2008 - OccuLogix, Inc. (NASD: OCCX) (Toronto: OC.TO) announced that its point-of-care diagnostics subsidiary, OcuSense, Inc., has received company-wide certification to ISO 13485:2003.
ISO, the International Organization for Standardization, is a worldwide federation of national standards bodies created to set standards for similar technologies in different countries. Details about ISO and its standards can be found at www.iso.org. The ISO 13485:2003 standard specifically focuses on the unique and rigorous requirements for companies involved in the development of medical devices. Achievement of ISO certification marks OcuSense's corporate commitment to quality in the design and manufacture its medical devices.
"The realization of our Beta Prototype along with our ISO certification represent significant milestones toward achieving commercial launch of our first product," commented Eric Donsky, OcuSense's Chairman & CEO. "We are looking forward to scaling commercial manufacturing of our TearLab(TM) Osmolarity System. We expect to attain CE Mark ahead of our initial product launch which is scheduled for 5 EU Countries later this year."
Elias Vamvakas, OccuLogix' Chairman and CEO, said, "The miniaturization of diagnostic devices, reducing costs, increasing throughput and enabling doctors to deliver a higher level of patient care by providing accurate laboratory test results at the point of care, is a growing movement and a major trend within medicine. OcuSense's achievement of ISO accreditation is an important milestone as we look toward our objective of FDA 510K clearance by the end of Q4 2008."
For more info: http://sgzh.realpennies.com
Songzai International Holding Group, Inc., through its subsidiary, produces coal by locating, assembling, assessing, permitting, and developing coal properties in the People's Republic of China. It operates TongGong coal mine located in the Heilongjiang Province in northeastern China. The company sells coal primarily to power plants, cement factories, whole sellers, and individuals for home heating. Songzai International Holding Group was founded in 2001 and is headquartered in Walnut, California.
April 10,2008 - Songzai International Holding Group, Inc. Reports 2007 Year-End Financial Results and Close of Acquisition Transaction
FY2007 Revenue Increases 222.03% to $12.6 Million as compared to $3.8 Million in FY2006
FY2007 Net Income Increases 479.6% to $4.08 Million as compared to $708,000 in FY2006
Songzai International Holding Group, Inc. (OTCBB: SGZH) (the "Company") a coal producer and reseller based in China, announced consolidated financial results for the fourth quarter and full year ended December 31, 2007.
In addition, on April 4, 2008, the Company closed a previously announced transaction to acquire a 90% equity stake in two Chinese coal mining companies: Heilongjiang Xing An Group Hong Yuan Coal Mining Co., Ltd. ("Hong Yuan") and Heilongjiang Xing An Group Sheng Yu Ming Co., Ltd. ("Sheng Yu"). Under the terms of the acquisition, Songzai issued 8 million shares of its common stock and promissory notes totaling $30 million to the owners of Hong Yuan and Sheng Yu. The 8 million shares are held in escrow for 2 years as security for certain indemnification obligations of the owners of Hong Yuan and Sheng Yu, except for those shares that may be sold under SEC Rule 144, which will be released from escrow as Rule 144 becomes available for their resale. 60% of the principal amount of the promissory notes are payable 6 months after the closing of the acquisition, and the balance on the first anniversary of the closing, provided that the entire balance will be due immediately if Songzai receives financing in excess of $30 million. The owners of Hong Yuan and Sheng Yu also placed the remaining 10% of these companies' equity in trust for the benefit of Songzai.
More detailed information about the acquisition of Hong Yuan and Sheng Yu, and Songzai's 2007 financial results may be found in the Company's Annual Report on Form 10-K filed with the SEC on April 10, 2008.
For more info: http://aqui.realpennies.com
AQUAGOLD branded premium Canadian Spring Water is presently being shipped into China. In 2005, sales of bottled water in China experienced strong growth of 16% (liters) and 15% (RMB/$) to reach 11.2 billion liters and RMB24.1 billion or $3.17 billion USD in volume and current value terms. The estimates on AQUAGOLD'S China contract alone exceed $500 million in revenues, however, how much in excess will follow in the near future resulting from ongoing marketing activities such as the upcoming trade show in Shanghai, China over the coming few weeks. AQUAGOLD is actively pursuing additional growth and is focused on growing market share in China as well as the rest of Asia, and the Company anticipates even more substantial opportunities in the near future as the Chinese capital city of Beijing hosts the 2008 Olympic Summer Games.
April 11,2008 -AQUAGOLD International, Inc. (OTC: AQUI) announced revenue details pertaining to its first announced consolidated sales contract. Following the announcement of partnership with WOLONG HOLDINGS, which now acts as distributor for AQUAGOLD's premium spring water products in China, AQUAGOLD today reveals details of its 8-year sales agreement. AQUAGOLD has proceeded with an initial consolidation of orders stemming from end users at the retail level. This consolidation results in a primary sales contract representing slightly fewer than 17 million cases of product for total revenue of $118 million dollars. The initial purchase orders and means of payment tied in with this contract are currently being finalized.
Daniel Sauve, AQUAGOLD's President and CEO, stated, "It is a pleasure to begin to release the highly anticipated details of our business. Our mission is to become the imported water of choice in China. With our strong relationships in China we have the necessary support and marketing structure to make this happen. These sales represent the first numbers of a larger picture soon to be seen by all. This picture is one of a company that works hand in hand with local partners from the ground up and understands what it takes to make AQUAGOLD's brand one of the most recognized in China."
ABOUT ERIC DAVID & SONS, INC.
Specializing in investor relations, Eric David & Sons, Inc. is a financial management, marketing and consulting firm that retains as clients only those who are perceived to offer unusual products or services with the potential to command a dominant position in their respective industry/marketplace and publicize companies with unique products services offerings whose stock is undervalued in relation to their long-term earnings potential.
For more info: http://udtt.realpennies.com
Universal Detection Technology engages in the research and development of bioterrorism detection devices in the United States. The company primarily offers the BSM-2000 device, an automated real-time bacterial spore detector, used for detection of abnormal levels of airborne endospores, such as anthrax. BSM-2000 is designed to provide unattended monitoring of airborne bacterial spores in public places, with real-time automated alert functionality. Universal Detection Technology also offers anthrax detection test kits, training material and references, and training DVDs and videos, as well as event security, research, and consulting. The company, formerly known as Pollution Research and Control Corporation, was founded in 1971. The company is headquartered in Beverly Hills, California.
April 11,2008 - Universal Detection Technology (OTCBB: UDTT) (Frankfurt: PO8.F) (www.udetection.com), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it has received purchase orders for its Anthrax kits from an Israeli security firm. The purchase order was placed by an Israeli security firm active in providing security solutions to clients all over Israel.
The Israeli government as well as private security firms are actively improving their preparedness for a bioterror attack as the potential threat of a bioterror attack from terror organizations and states with active biological weapon programs, such as Syria, grows. For example, large numbers of the Israeli population have received smallpox inoculations.
UDTT's anthrax detection kits have provided accurate results to users in the field in as little as three minutes. The kits have been purchased by first responders throughout the country as well as the U.S. Army. The kits are able to detect anthrax spores well below the threshold for an infectious dose.
"The purchase order from Israel is a milestone for us as we our providing detection kits to a firm that deals with terrorist-related activities on a weekly basis," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer. "We plan to expand our efforts in providing detection solutions to our partner in Israel," he added.
Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html
Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html
Sponsored by: http://www.isthemarketopen.com
RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com
No comments:
Post a Comment